"Executive Summary Asia-Pacific Gene Therapy Market Size and Share: Global Industry Snapshot Data Bridge Market Research analyzes that the Asia-Pacific gene therapy market is expected to reach USD  4,441.14 million by 2030, at a CAGR of 19.0% during the forecast period. Product accounts for the most significant type segment in the market due to the growing use of exosome...

"In-Depth Study on Executive Summary Europe Gene Therapy Market Size and Share Data Bridge Market Research analyzes that the Europe gene therapy market is expected to reach USD  7,422.28 million by 2030, at a CAGR of 17.6% during the forecast period. Product accounts for the most significant type segment in the market due to the growing use of exosome research products in...

"Executive Summary Gene Therapy Market: Growth Trends and Share Breakdown The global gene therapy market size was valued at USD 10.26 billion in 2024 and is expected to reach USD 39.38 billion by 2032, at a CAGR of 18.30% during the forecast periodThe market growth is largely fueled by the growing demand for curative therapies and rising investments in gene therapy research. Technological...

The treatment for Hemophilia, a challenging inherited bleeding disorder, has historically involved frequent, costly intravenous injections of clotting factors. However, we are entering a new era of medicine where a one-time treatment may offer a near-cure. Gene therapy—the process of introducing a functional copy of the deficient clotting factor gene directly into a patient’s...

"Global Executive Summary Middle East and Africa Gene Therapy Market: Size, Share, and Forecast Data Bridge Market Research analyzes that the Middle East and Africa gene therapy market  is expected to reach the value of USD  1,019.11 million by 2030, at a CAGR of 16.6% during the forecast period. Product accounts for the largest type segment in the market due to growing use of...

"Comprehensive Outlook on Executive Summary North America Gene Therapy Market Size and Share Data Bridge Market Research analyzes that the North America gene therapy market is expected to reach USD 13,418.96 million by 2030, at a CAGR of 18.8% during the forecast period. Product accounts for the most significant type segment in the market due to the growing use of exosome research...

Introspective Market Research, a leader in pharmaceutical and healthcare intelligence, today published its deep-dive analysis into the Global Campomelic Syndrome Treatment Market . Campomelic Syndrome (CS) is a rare and often life-threatening genetic disorder characterized by severe skeletal malformations, which necessitates intensive supportive and specialized care. The market, which focuses...

Introspective Market Research, a provider of high-value industry analysis, today announced the publication of its latest report on the Global DNA Nanotechnology Market . This market focuses on designing and using DNA strands as programmable structural materials to construct complex, functional nanomachines and devices, offering unprecedented control over biological systems. The DNA...

Introspective Market Research (IMR) has unveiled its latest strategic analysis on the Global Osteogenesis Imperfecta (OI) Treatment Market . The report highlights the critical role of specialized pharmaceuticals and emerging gene therapies in managing this rare, inherited connective tissue disorder, often referred to as "brittle bone disease." The market, which was valued at USD 722.9 Million...

According to a new report published by Introspective Market Research, Personalized Cell Therapy Market by Therapy Type, Therapeutic Area, and End-User, The Global Personalized Cell Therapy Market Size Was Valued at USD 15.10 Billion in 2023 and is Projected to Reach USD 114.63 Billion by 2032, Growing at a CAGR of 25%.”   Introduction / Market Overview: The global personalized...

Global Executive Summary RNA Therapeutics Market: Size, Share, and Forecast During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine   While preparing the first class RNA Therapeutics...